美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物科技指数ETF-iShares Nasdaq

204.26

-2.2300-1.08%

盘后：204.260.00000.00%19:47 EDT

成交量：115.73万

成交额：2.37亿

市值：107.13亿

市盈率：32.36

高：206.93

开：206.85

低：203.92

收：206.49

52周最高：217.12

52周最低：149.09

股本：5,245.00万

流通股本：5,245.00万

量比：0.50

换手率：2.21%

股息：0.33

股息率：0.16%

每股收益(TTM):6.31

每股收益(LYR):35.34

净资产收益率：24.54%

总资产收益率：0.10%

市净率：1.32

市盈率(LYR):5.78

数据加载中...

总览公司新闻资讯公告

福泰制药(VRTX)股票10月1日盘中下跌3.21%：真相来了

TradingKey中文

再生元制药：LGSOC患者中21%出现3级及以上严重治疗相关不良事件；74%发生TRAE；中性粒细胞减少、贫血、肝酶升高

再生元制药：Ubamatamab在LGSOC患者中实现73%客观缓解率及11个月中位无进展生存期

Ubamatamab（Muc16xcd3）在晚期低级别浆液性卵巢癌（Lgsoc）患者的初步研究中展现出高比例的持久缓解

再生元制药：Trevogrumab可阻止司美格鲁肽治疗相关的70%肌肉流失

2期Courage试验证实：Trevogrumab可防止GLP-1受体激动剂减重过程中瘦体重与肌肉流失

再生元制药：Trevogrumab低剂量耐受性良好，77%受试者出现至少一种不良事件

再生元制药高管：REGN20423关键性研究预计2027年末至2028年初启动

赛诺菲高管称“目前尚无定论，但我们正积极设法延长Dupixent的独占权丧失”

再生元制药高管：随着首个后期试验作为交易一部分启动，公司有资格获得10亿美元潜在里程碑付款——电话会议

赛诺菲CEO：预计未来五年特应性皮炎治疗市场将近乎翻倍——电话会议

今日关注个股：美光科技、谷歌A、赛诺菲、Nu Holdings

三星生物制药与梯瓦制药扩大战略合作，推进至多六款候选生物类似药研发.

赛诺菲与再生元通过一项80亿美元的药物研发协议扩大合作，并解决了法律纠纷

赛诺菲将在扩大免疫学合作协议中向瑞杰纳隆支付10亿美元预付款

赛诺菲与再生元制药达成合作协议，将均摊开发及商业化成本，共享未来利润

赛诺菲与再生元将获10亿美元预付款未来里程碑付款最高或达70亿美元

临床试验显示，Regeneron的药物与诺和诺德的司美格鲁肽联用可将肌肉流失减少一半

数据简报-大型制药公司纷纷转向中国寻求许可协议

港股异动 | 中国生物制药(01177)涨近4% 附属与STADA就生物类似药达成战略合作首付款获最高达5300万欧元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/IBB/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指数ETF-iShares Nasdaq","latestPrice":204.26,"timestamp":1791835200000,"preClose":206.49,"halted":0,"volume":1157283,"hourTrading":{"tag":"盘后","latestPrice":204.26,"preClose":204.26,"latestTime":"19:47 EDT","volume":10034,"amount":2049515.9148,"timestamp":1791848828793,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.010799554457843082,"floatShares":52450000,"shares":52450000,"eps":6.311863,"marketStatus":"未开盘","change":-2.23,"latestTime":"10-12 16:00:00 EDT","open":206.85,"high":206.93,"low":203.92,"amount":237090797.56701,"amplitude":0.014577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":206.49,"sharesOutstanding":49450000,"nav":206.296467,"aum":10840879340.85,"dividendRate":0.001618,"bidAskSpread":0.000349,"preHourTrading":{"tag":"盘前","latestPrice":206.5,"preClose":206.49,"latestTime":"09:27 EDT","volume":190,"amount":39274.1248,"timestamp":1791811645668,"change":0.01,"changeRate":0.000048,"amplitude":0.029869},"postHourTrading":{"tag":"盘后","latestPrice":204.26,"preClose":204.26,"latestTime":"19:47 EDT","volume":10034,"amount":2049515.9148,"timestamp":1791848828793,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.501392,"impliedVol":0.2474,"impliedVolPercentile":0.7012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":52450000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.501392,"shares":52450000,"dividePrice":0.3304,"high":206.93,"amplitude":0.014577,"preClose":206.49,"low":203.92,"week52Low":149.0909,"pbRate":"1.32","psRate":"257.76","week52High":217.12,"institutionHeld":0,"latestPrice":204.26,"eps":6.311863,"divideRate":0.001618,"volume":1157283,"delay":0,"ttmEps":6.311863,"open":206.85,"prevYearClose":168.77,"prevWeekClose":206.49,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":207.96,"twentyDayClose":204.6,"sixtyDayClose":189.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672617297","title":"福泰制药(VRTX)股票10月1日盘中下跌3.21%：真相来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2672617297","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672617297?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 03:16","pubTimestamp":1790882174,"startTime":"0","endTime":"0","summary":"• 美债收益率高企与高估值对 Vertex 股价造成了下行压力。\n• 对 Crinetics 的收购促使投资者重点关注资本配置与整合效率。\n• 技术指标显示 MACD 卖出信号和威廉指标（Williams %R）超卖。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262196795-market-movers-vrtx-20261001","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","BK4139","IE00B2B36J28.USD","LU0889565916.HKD","LU2417539215.USD","LU0289739699.SGD","SG9999001176.SGD","BBH","BK4588","LU2468319806.SGD","LU2362540622.SGD","VRTX","BK4585","LU2456880835.USD","GNMX","IBB","LU2362541513.USD","BIB","LU0234570918.USD","SG9999013999.USD","LU0823416689.USD","IE00B19Z9P08.USD","TBXU","IBBQ","IDNA","LU2237438978.USD","LU0417517546.SGD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","LU0432979614.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU1093756168.USD","LU1674673428.USD","IE00BZ9MQY76.HKD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1778281490.HKD","SGXZ57979304.SGD","LU1430594728.SGD","LU2089984988.USD","PBE","IE00BJJMRZ35.SGD","LU2362541273.HKD","LU1069344957.HKD","IE00B19Z3B42.SGD","BK4532","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191410459","title":"再生元制药：LGSOC患者中21%出现3级及以上严重治疗相关不良事件；74%发生TRAE；中性粒细胞减少、贫血、肝酶升高","url":"https://stock-news.laohu8.com/highlight/detail?id=1191410459","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191410459?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 23:37","pubTimestamp":1790869028,"startTime":"0","endTime":"0","summary":"再生元制药公司披露数据：在LGSOC患者群体中，21%出现3级及以上的严重治疗相关不良事件；治疗相关不良事件总体发生率达74%；具体表现包括中性粒细胞减少、贫血以及肝酶升高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BBH","IBBQ","BK4585","LU2362541513.USD","LU0058720904.USD","LU0823434740.USD","LU2468319806.SGD","LU0109394709.USD","LU2324357040.USD","LU2089984988.USD","BK4139","REGN","BK4588","LU2106854487.HKD","LU0889565916.HKD","LU2362541273.HKD","LU2362540622.SGD","LU2237438978.USD","LU0823416689.USD","LU0289739699.SGD","IBB","LU1917777945.USD","LU0114720955.EUR","LU0882574055.USD","LU1974910355.USD","LU0823434583.USD","LU0320765992.SGD","LU0053666078.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138589308","title":"再生元制药：Ubamatamab在LGSOC患者中实现73%客观缓解率及11个月中位无进展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1138589308","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138589308?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 23:36","pubTimestamp":1790868969,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，Ubamatamab在低级别浆液性卵巢癌（LGSOC）患者中展现出73%的客观缓解率，中位无进展生存期达到11个月。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2468319806.SGD","LU2023250504.SGD","IBBQ","LU0053666078.USD","LU2089984988.USD","LU2237438978.USD","LU2324357040.USD","BK4585","REGN","LU0289739699.SGD","BBH","LU0114720955.EUR","TBXU","IBB","LU0109394709.USD","LU0889565916.HKD","LU0823416689.USD","BK4139","LU0882574055.USD","BK4588","LU2362541513.USD","LU0823434583.USD","LU1917777945.USD","LU0823434740.USD","LU1974910355.USD","LU2362540622.SGD","LU2106854487.HKD","LU0320765992.SGD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174532999","title":"Ubamatamab（Muc16xcd3）在晚期低级别浆液性卵巢癌（Lgsoc）患者的初步研究中展现出高比例的持久缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=1174532999","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174532999?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 23:36","pubTimestamp":1790868968,"startTime":"0","endTime":"0","summary":"Ubamatamab（Muc16xcd3）在晚期低级别浆液性卵巢癌（Lgsoc）患者的初步研究中展现出高比例的持久缓解","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2324357040.USD","BK4588","BK4139","LU2362541513.USD","LU0882574055.USD","LU0109394709.USD","LU0823416689.USD","BK4585","LU2089984988.USD","TBXU","LU0823434583.USD","LU0320765992.SGD","LU0889565916.HKD","LU2362541273.HKD","IBB","LU2468319806.SGD","BBH","LU0053666078.USD","LU0823434740.USD","LU0289739699.SGD","LU2023250504.SGD","LU1917777945.USD","LU2362540622.SGD","LU2237438978.USD","LU0058720904.USD","LU2106854487.HKD","IBBQ","LU0114720955.EUR","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121363783","title":"再生元制药：Trevogrumab可阻止司美格鲁肽治疗相关的70%肌肉流失","url":"https://stock-news.laohu8.com/highlight/detail?id=1121363783","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121363783?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868936,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，Trevogrumab能够防止与司美格鲁肽治疗相关的70%肌肉流失。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","LU2468319806.SGD","LU2362541513.USD","IBBQ","BK4585","LU2362540622.SGD","BK4588","LU1974910355.USD","BK4139","LU2089984988.USD","TBXU","LU0823434740.USD","REGN","LU0320765992.SGD","LU0058720904.USD","LU0889565916.HKD","BBH","IBB","LU2362541273.HKD","LU0882574055.USD","LU2237438978.USD","LU0289739699.SGD","LU2324357040.USD","LU0823416689.USD","LU2106854487.HKD","LU0053666078.USD","LU2023250504.SGD","LU0109394709.USD","LU1917777945.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177277221","title":"2期Courage试验证实：Trevogrumab可防止GLP-1受体激动剂减重过程中瘦体重与肌肉流失","url":"https://stock-news.laohu8.com/highlight/detail?id=1177277221","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177277221?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 23:31","pubTimestamp":1790868668,"startTime":"0","endTime":"0","summary":"2期Courage试验证实，Trevogrumab能够有效阻止GLP-1受体激动剂诱导的减重过程中出现的瘦体重和肌肉流失。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU2362540622.SGD","LU0823434583.USD","TBXU","LU1974910355.USD","LU2468319806.SGD","LU0320765992.SGD","LU1917777945.USD","LU0058720904.USD","LU2106854487.HKD","LU2237438978.USD","LU2362541273.HKD","IBBQ","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","LU0823416689.USD","BK4139","LU2023250504.SGD","BK4585","LU2362541513.USD","IBB","BBH","LU0882574055.USD","LU0053666078.USD","BK4588","REGN","LU2324357040.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136668911","title":"再生元制药：Trevogrumab低剂量耐受性良好，77%受试者出现至少一种不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1136668911","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136668911?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 23:31","pubTimestamp":1790868667,"startTime":"0","endTime":"0","summary":"再生元制药公司披露，Trevogrumab在较低剂量下展现出良好的耐受性，但77%的受试者仍经历了至少一种不良事件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK4139","IBBQ","IBB","LU1917777945.USD","LU2362541273.HKD","BBH","LU0889565916.HKD","LU0320765992.SGD","LU2106854487.HKD","LU2468319806.SGD","LU0289739699.SGD","LU2362540622.SGD","LU0058720904.USD","BK4585","LU2324357040.USD","LU0114720955.EUR","LU2362541513.USD","LU2023250504.SGD","REGN","LU0823434740.USD","LU0823434583.USD","LU1974910355.USD","LU2237438978.USD","TBXU","BK4588","LU0882574055.USD","LU0823416689.USD","LU0109394709.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121787391","title":"再生元制药高管：REGN20423关键性研究预计2027年末至2028年初启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1121787391","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121787391?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 20:58","pubTimestamp":1790859498,"startTime":"0","endTime":"0","summary":"再生元制药公司高管表示，公司预计将于2027年末或2028年初启动针对REGN20423的关键性研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU1974910355.USD","BBH","LU2468319806.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0823434583.USD","BK4585","BK4588","REGN","IBB","LU2362541273.HKD","LU0289739699.SGD","LU0882574055.USD","LU0823434740.USD","LU1917777945.USD","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU2324357040.USD","TBXU","BK4139","LU0114720955.EUR","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124557622","title":"赛诺菲高管称“目前尚无定论，但我们正积极设法延长Dupixent的独占权丧失”","url":"https://stock-news.laohu8.com/highlight/detail?id=1124557622","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124557622?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 20:54","pubTimestamp":1790859259,"startTime":"0","endTime":"0","summary":"赛诺菲高管表示：“眼下尚无任何定论，但我们正积极行动，力求延缓Dupixent失去市场独占权的进程。”","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2362541273.HKD","LU0882574055.USD","LU2324357040.USD","LU0823434583.USD","LU0320765992.SGD","LU0114720955.EUR","LU2089984988.USD","BBH","LU2023250504.SGD","IBB","BK4585","LU1974910355.USD","LU0058720904.USD","LU0823416689.USD","LU0289739699.SGD","BK4588","LU1917777945.USD","LU2362541513.USD","LU0109394709.USD","LU2362540622.SGD","LU2468319806.SGD","BK4139","LU0823434740.USD","REGN","TBXU","IBBQ","LU0053666078.USD","LU2106854487.HKD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105425611","title":"再生元制药高管：随着首个后期试验作为交易一部分启动，公司有资格获得10亿美元潜在里程碑付款——电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1105425611","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105425611?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 20:48","pubTimestamp":1790858923,"startTime":"0","endTime":"0","summary":"再生元制药高管：随着首个后期试验作为交易一部分启动，公司有资格获得10亿美元潜在里程碑付款——电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU2468319806.SGD","LU2023250504.SGD","LU2106854487.HKD","IBBQ","IBB","LU0823416689.USD","LU0823434740.USD","LU0109394709.USD","BK4139","BK4585","LU2089984988.USD","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU1917777945.USD","LU1974910355.USD","LU0114720955.EUR","LU0889565916.HKD","LU2362541513.USD","LU2324357040.USD","LU2362541273.HKD","LU2362540622.SGD","BK4588","LU0823434583.USD","LU0289739699.SGD","TBXU","BBH","REGN","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188473511","title":"赛诺菲CEO：预计未来五年特应性皮炎治疗市场将近乎翻倍——电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1188473511","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188473511?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 20:25","pubTimestamp":1790857508,"startTime":"0","endTime":"0","summary":"赛诺菲首席执行官在电话会议上表示，预计未来五年内，特应性皮炎治疗市场的规模将接近翻番。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2324357040.USD","BK4585","LU0289739699.SGD","LU2362540622.SGD","LU2362541513.USD","LU0109394709.USD","LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU2468319806.SGD","BBH","BK4588","LU2362541273.HKD","LU2023250504.SGD","LU0823434583.USD","LU1917777945.USD","LU0823434740.USD","TBXU","LU1974910355.USD","LU0053666078.USD","IBBQ","LU2106854487.HKD","LU0058720904.USD","REGN","BK4139","LU0882574055.USD","IBB","LU2089984988.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107668699","title":"今日关注个股：美光科技、谷歌A、赛诺菲、Nu Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=1107668699","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107668699?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 18:07","pubTimestamp":1790849272,"startTime":"0","endTime":"0","summary":"谷歌A：这家谷歌母公司的股价在盘前上扬，此前该公司于昨日发布了其最新人工智能模型Gemini 4 Argon。该交易对Meteoric的估值约为6.72亿美元，将让Lynas得以切入巴西不断成长的稀土产业。Nu Holdings Ltd.：这家巴西数字银行的股价在盘前跃升，此前Nu于昨日发表声明，否认其正在寻求收购英国金融科技公司Monzo。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0957808578.USD","LU2065171311.SGD","SG9999015952.SGD","LU0496365809.HKD","LU2045819591.USD","BK4207","LU0976567544.SGD","IE00B7KXQ091.USD","BK4550","LU2089985449.USD","LU1430594728.SGD","SG9999015358.SGD","LU0056508442.USD","IE00BKPKM429.USD","LU0472753341.HKD","LU1989772840.SGD","LU2242649171.HKD","LU0823416689.USD","LU1400636574.HKD","LU0395794307.EUR","LU0572108347.SGD","LU0196696701.USD","BBH","FDTX","LU1988902786.USD","LU2048586759.USD","LU0985320562.USD","LU0175139822.USD","LU0211327993.USD","LU0942090050.USD","LU2347655073.USD","TBXU","LU0661504455.SGD","WLDR","LU0957791311.USD","LU2211815571.USD","IE00BGV7N243.SGD","LU2458330169.SGD","LU0345768740.USD","SG9999015945.SGD","FCOM","LU0157215616.USD","AIS","LU2404859741.USD","LU1868836591.USD","LU0868494708.USD","LU0912757837.SGD","LU1116320901.HKD","LU2237438978.USD","LU2092937148.SGD","IE00B1BXHZ80.USD","LU1496350502.SGD","LU1551013425.SGD","LU0456842615.SGD","GOU","LU1228905540.USD","LU2168564065.EUR","LU0006306889.USD","LU2357627491.SGD","BK4559","SG9999002224.SGD","LU2028103732.USD","LU0320765489.SGD","LU0196696453.USD","LU1935042991.SGD","LU1066051811.HKD","LU1280957306.USD","SGXZ51526630.SGD","LU1880398554.USD","LU0348723411.USD","LU0289960550.SGD","LU0642271901.SGD","LU0980610538.SGD","LU0130518102.USD","LU1791710400.SGD","LU2756315664.SGD","LU2896262040.SGD","IE0004445015.USD","GB00B4QBRK32.GBP","LU1323610961.USD","LU0128525929.USD","SGXZ31699556.SGD","LU0310800965.SGD","LU1674673691.USD","HK0000914660.USD","LU1880398471.USD","LU2505996509.AUD","LU2468319806.SGD","LU2065169927.USD","LU2264538146.SGD","LU0726765562.USD","CHAT","LU0788109048.HKD","MUD","LU0476273544.USD","BK4598","IE00B19Z8X17.USD","LU0354030511.USD","LU0109392836.USD","IE00BJTD4V19.USD","LU0314104364.USD","METV","LU1267930813.SGD","LU0323239441.USD","LU0719512351.SGD","LYC.AU","LU2360107168.USD","IE00BWXC8680.SGD","IE000M9KFDE8.USD","LU1894683348.USD","LU2097829019.USD","LU2491050071.SGD","LU0198837287.USD","LU1935042488.USD","LU0342679015.USD","LU1894683264.USD","LU2265009873.SGD","LU0265550946.USD","LU0086394185.USD","BK4503","LU0256863902.USD","IE00B19Z3B42.SGD","LU1244550221.USD","LU2023251221.USD","LU1815336760.USD","LU1084165304.USD","BK4575","LU0310800379.SGD","SG9999000418.SGD","LU0889565833.HKD","GOOGL","LU0396314238.USD","MIC","LU0823421333.USD","LU0109394709.USD","LU0545562505.USD","MU","SMH","LU1732800096.USD","LU0174119429.USD","LU2125909593.SGD","MUG","IE0034235295.USD","IE00BMPRXQ63.HKD","LU0094547139.USD","LU0124676726.USD","LU1803068623.USD","XDAT","LU0069063385.USD","LU0107464264.USD","LU0238689110.USD","LU2089284900.SGD","REGN","BK4543","LU2250418816.HKD","SG9999014559.SGD","LU1868837300.USD","LU0058720904.USD","LU2065170008.USD","IE00BFXG0V08.USD","LU2125910500.SGD","CGGO","GB00BDT5M118.USD","LU2360106780.USD","LU2746668974.SGD","LU0256863811.USD","IE00BN8TJ469.HKD","IETC","LU0130517989.USD","LU0820561818.USD","LU1815333072.USD","LU2125154935.USD","LU0097036916.USD","LU1804176565.USD","LU0170899867.USD","LU0943347566.SGD","LU0133085943.USD","JGRO","LU2931357623.SGD","LU0234572021.USD","LU0203345920.USD","LU0683600562.USD","IE0000B7K699.USD","LU2420271590.USD","LU2087625088.SGD","LU0823046494.USD","LU0345770308.USD","FTXL","LU2191332357.HKD","LU0898699433.AUD","IE00BDRTCR15.USD","SMU00main","HK0000304805.HKD","LU0251132253.USD","LU0689626769.HKD","IE00BJJMRY28.SGD","LU0784383803.USD","LU1301847155.USD","LU2271345857.HKD","LU1144417596.USD","LU1791710582.SGD","LU0859254822.USD","LU1674673428.USD","LU1629891620.HKD","LU0289739343.SGD","LU0276348264.USD","LU0553294199.USD","SKYY","LU0345768153.USD","LU1066053197.SGD","LU1121112475.USD","FAI","LU2023250330.USD","IE0002270589.USD","LU0323240290.USD","LU2168564222.USD","LU0889566641.SGD","LU0254981946.USD","LU1201861165.SGD","LU1119994496.HKD","LU2054465674.USD","LU0274383776.USD","LU0823434583.USD","LU0214875030.USD","IE00BZ1G4Q59.USD","LU0096364046.USD","LU2403377893.USD","SGXZ99366536.SGD","GOOP","IE00BFSS8Q28.SGD","IBBQ","IE00BFSS7M15.SGD","LU0320765059.SGD","LU0072463663.USD","LU2462591277.SGD","LU0251143458.SGD","LTL","BK4573","LU0289961442.SGD","LU2290526834.HKD","EGGY","LU0057025933.USD","LU0053666078.USD","PSI","LU0234570918.USD","BK7095","HK0000819398.USD","IE00BQXX3C00.GBP","TRFK","USXF","WUGI","IE00BSNM7G36.USD","LU1699723380.USD","LU0689472784.USD","LU1718418525.SGD","RULE","LU0320765992.SGD","IE000WAW04H5.SGD","LU1868838027.USD","LU2362540622.SGD","LU2133065610.SGD","IE00BLSP4239.USD","LU0795875169.SGD","LU0096362180.USD","IE000MB6IJN5.SGD","LU0784384876.USD","LU2168564495.EUR","LU0426417589.USD","SOXQ","LU0742534661.SGD","LU0823434740.USD","LU0708995401.HKD","IE00B1B80R65.USD","IE000SO60NU8.SGD","LU1267930573.SGD","LU0314106906.USD","LU0130103400.USD","IE0034235303.USD","LU1923623000.USD","LU1043141396.HKD","CMAG","GOOY","AIQ","LU0477156797.USD","LU1429558221.USD","LU0106261372.USD","BK4134","LU2543165471.USD","FTEC","SG9999014880.SGD","LU2097344357.USD","LU0312595415.SGD","LU0048584097.USD","LU1400636491.USD","NKE","SG9999018857.SGD","LU1823568750.SGD","LU1951200564.SGD","LU1852331112.SGD","ACN","VGT","LU1196500208.SGD","LU2491049909.HKD","LU0354030438.USD","PTF","LU1153585028.USD","IE00BK4W5L77.USD","LU2505996681.GBP","LU2750360641.GBP","BK4141","LU1366333091.USD","LU2111349929.HKD","IE0004086264.USD","IE00BQXX3F31.USD","LU0466842654.USD","LU1917777945.USD","LU2092627202.USD","LU0158827781.USD","SG9999004303.SGD","LU0265550359.USD","ARTY","LU2077746001.SGD","LU1989772923.USD","MUYY","LU0949170426.SGD","LU1232071149.USD","NU","SG9999014898.SGD","LU1989764664.SGD","SGXZ81514606.USD","MEI.AU","LEGR","BK4602","LU1868836914.USD","LU2471134796.USD","HK0000304797.USD","LU1720051017.SGD","LU1633808545.USD","LU2999663052.SGD","GOOL","LU1316542783.SGD","LU2954938101.SGD","LU2242650005.HKD","IE00BMPRXN33.USD","LU0528227936.USD","LU0323591593.USD","DISK","LU2347655156.SGD","BK4592","LU0053687314.USD","IE00BYQQ9H92.USD","LU0109391861.USD","LU0310799852.SGD","BK7507","LU2063271972.USD","LU0061475181.USD","IE0001KFT4U8.USD","SNPE","IE0004091025.USD","IE00BLSP4452.SGD","LU0210536198.USD","HK0000532082.HKD","LU2602419157.SGD","BAI","LU0640476718.USD","LU0648001328.SGD","LU2089283258.USD","IXN","LU1571399168.USD","CQTM","LU1868836757.USD","BK4553","LU0061474705.USD","LU1267930730.SGD","IE00BKDWB100.SGD","GXPC","LU0511384066.AUD","LU2756315318.SGD","IE00BHPRN162.USD","LU0029864427.USD","LU2362541513.USD","LU1221951129.SGD","LU0444973449.USD","LU2102340556.USD","LU0786609619.USD","LU1435385759.SGD","LU2458330243.SGD","LU0143551892.USD","LU0210533765.USD","LU0784385840.USD","LU0792757196.USD","LU0302445910.USD","MUU","LU2462591350.SGD","LU0061474960.USD","BK4512","LU1868837565.USD","LU0820561909.HKD","LU2247934214.USD","LU2360032135.SGD","LU0690374961.EUR","LU1267930227.SGD","BK4558","LU1228905037.USD","LU2404859667.USD","LU1914381329.SGD","LU0048575426.USD","IE00BQXX3D17.EUR","LU0994945656.USD","IE00BJLML261.HKD","IE00BFMHRM44.USD","IE00B5949003.HKD","LU0154236417.USD","LU1032955483.USD","IE0009356076.USD","LU1003077747.HKD","LU1935042215.USD","LU2471134523.USD","LU0267386448.USD","LU0225283273.USD","LU2860962120.EUR","EMSF","DRMY","LU0265267285.USD","LU1064131342.USD","MULL","LU0823421416.USD","LU0823046577.USD","LU0648000940.SGD","LU2471134879.HKD","LU1883839398.USD","XNTK","LU0672654240.SGD","LU1951198990.SGD","LU0143863784.USD","LU0690374615.EUR","LU0820562030.AUD","LU2087621335.USD","BK4561","BK4532","HBMX","LU0011850046.USD","LU1116320737.USD","LU2381873111.SGD","BK4585","LU0545039389.USD","GOGL","SG9999014567.USD","SG9999018865.SGD","EFIV","LU0531970944.HKD","LU0048573561.USD","LU0081259029.USD","LU1221951046.USD","LU0964807845.USD","SG9999002232.USD","LU0889565916.HKD","LU1670627923.USD","SG9999017495.SGD","LU0868494617.USD","LU1732799900.SGD","LU2106854487.HKD","SG9999015341.SGD","IE00BJTD4N35.SGD","LU1803068979.SGD","LU1720051108.HKD","LU0211326839.USD","LU0114720955.EUR","LU2023250504.SGD","LU0426412945.USD","LU1145028129.USD","LU0449509016.USD","LU1839511570.USD","IE00B19Z3581.USD","OGIG","XLC","LU0417517546.SGD","LU0215105999.USD","LU2286300806.USD","LU0158827948.USD","LU1046421795.USD","LU0345769631.USD","LU0882574139.USD","IE00B7SZLL34.SGD","BK4533","IE00BYXW3230.USD","LU2430703251.USD","SOXX","IE00B19Z8W00.USD","SG9999014542.SGD","LU1066051498.USD","LU2213496289.HKD","LU1201861249.SGD","LU1670756490.USD","LU1645745479.HKD","BK4146","BK4574","SNYNF","LU0052756011.USD","LU1935043023.USD","LU0080751232.USD","LU2471134952.CNY","LU0070217475.USD","LU2430703095.HKD","LU0795875086.SGD","BK4554","LU2065171402.SGD","LU2275660780.HKD","IBB","BK4077","LU2592432038.USD","VOX","BK4612","LU1868837136.USD","LU1032466523.USD","ILDR","SGXZ23171101.USD","LU0708994859.HKD","BK4514","LU1261432733.SGD","MUZ","LU0106259046.USD","LU1366192091.USD","LU1974910355.USD","BK4579","LU1935043536.SGD","LU1267930490.SGD","BK4534","CHPX","GGLS","LU0211331839.USD","LU1923622614.USD","LU0127658192.USD","GGLL","LU0211328371.USD","SG9999015986.USD","LU0557290698.USD","IE00BJJMRX11.SGD","LU1861215975.USD","LU1548497426.USD","LU0211326755.USD","SG9999001424.SGD","LU0353189680.USD","LU2357305700.SGD","LU0494093205.USD","LU0128525689.USD","BK4139","LU1244550577.SGD","BK4007","LU2125154778.USD","IE00BK4W5M84.HKD","GB00B4LPDJ14.GBP","LU0256859116.SGD","LU0823411888.USD","LU0316494557.USD","IE000F7OJYX1.SGD","LU1066051225.USD","IE00B1XK9C88.USD","LU0077335932.USD","LU0345774391.USD","LU0261950470.USD","LU2244417387.USD","LU0265266980.USD","BK4581","LU2168563687.JPY","LU2362541273.HKD","LU0138981039.USD","LU2098885051.SGD","LU2168564149.EUR","LU2360107671.USD","AIFD","LU1506573853.SGD","LU2462157665.USD","LU2023250843.SGD","LU0070302665.USD","LU1202635105.USD","LU0050427557.USD","LU0787776722.HKD","LU0949170772.SGD","LU2326559502.SGD","LU1059921491.USD","LU1935043452.HKD","LU2417539215.USD","LU0289739699.SGD","LU1043141123.HKD","LU1496350171.SGD","LU1861217088.USD","LU1861220207.SGD","TRUC","SG9999014914.USD","IE00BBT3K403.USD","HK0000914686.HKD","BK4576","GOOW","IE00BDCRKT87.USD","LU1481012133.USD","BK4538","LU0882574055.USD","LU2491050154.USD","LU2125909247.SGD","LU0345774631.USD","SG9999015978.USD","LU0082616367.USD","IE00B19Z9505.USD","STYL","LU1235294995.USD","LU1551013342.USD","LU1303367103.USD","CHPS","BK4588","LU2433249047.HKD","IE00BMPRXR70.SGD","LU0251142724.SGD","LU2746668461.USD","LU1861220033.SGD","LU2430703178.SGD","LU2750360997.AUD","LU0353189763.USD","LU0210535034.USD","SGXZ44715902.SGD","SG9999014906.USD","LU0143863198.USD","LU1989764748.USD","LU0477156953.USD","LU2596442595.SGD","LU2324357040.USD","LU0444971666.USD","LU1778281490.HKD","BK4605","LU1244550494.USD","GOOX","LU0187121727.USD","TTXU","LU0738911758.USD","LU0531971322.HKD","LU1400636657.SGD","XLK","IE000BZT7R73.USD","LU2456880835.USD","LU0784385170.HKD","LU0251131958.USD","LU0208291251.USD","NUG","LU0203347892.USD","SG9999014575.USD","LU1585245621.USD","LU2097344431.USD","IE00BD6J9T35.USD","BK4566","LU0149725797.USD","LU1642822529.SGD","LU0130102774.USD","IE0034235188.USD","SHOC","BOBP","IE00BKVL7J92.USD","LU0345769128.USD","FXL","LU2089984988.USD","BK4527","LU2236285917.USD","SGXZ80539844.SGD","LU0345770993.USD","LU1670628061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672753398","title":"三星生物制药与梯瓦制药扩大战略合作，推进至多六款候选生物类似药研发.","url":"https://stock-news.laohu8.com/highlight/detail?id=2672753398","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672753398?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 16:30","pubTimestamp":1790843422,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4596","LU2322448791.USD","LU2324357040.USD","BK4557","BBP","BK4566","LU1992135472.HKD","LU1983299246.USD","TEVA","IBB","BK4585","XPH","LU2473716301.USD","BK4584","LU2272731600.USD","BK4588","BK4559","LU2322448957.HKD","BK4007","MRNX","LU2272731782.SGD","EMXC","IBBQ","LU2272731865.HKD","MRNY","PPH","IE00B5TLWC47.USD","LU1992135399.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672073401","title":"赛诺菲与再生元通过一项80亿美元的药物研发协议扩大合作，并解决了法律纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2672073401","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672073401?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 13:41","pubTimestamp":1790833281,"startTime":"0","endTime":"0","summary":"赛诺菲将预付10亿美元，并可能根据里程碑达成额外支付70亿美元。双方将平分这四款药物的研发成本和未来利润，其中再生元负责主导研发，若获批上市，赛诺菲将负责全球销售。周四，赛诺菲股价收盘上涨近1%。其余三种药物预计将于2027年启动临床试验。2025年，Dupixent占赛诺菲近440亿欧元 销售额的36%。赛诺菲表示正在积极寻求延长Dupixent的专利独占期，但拒绝透露具体细节。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4S45N0C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2324357040.USD","BK4588","BK4139","LU2362541513.USD","LU0882574055.USD","LU0109394709.USD","LU0823416689.USD","BK4585","LU2089984988.USD","TBXU","LU0823434583.USD","LU0320765992.SGD","LU0889565916.HKD","LU2362541273.HKD","IBB","LU2468319806.SGD","BBH","LU0053666078.USD","LU0823434740.USD","LU0289739699.SGD","LU2023250504.SGD","LU1917777945.USD","LU2362540622.SGD","LU2237438978.USD","LU0058720904.USD","LU2106854487.HKD","IBBQ","LU0114720955.EUR","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734953","title":"赛诺菲将在扩大免疫学合作协议中向瑞杰纳隆支付10亿美元预付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734953","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734953?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 13:15","pubTimestamp":1790831736,"startTime":"0","endTime":"0","summary":"赛诺菲将在扩大免疫学合作协议中向瑞杰纳隆支付10亿美元预付款路透10月1日-法国制药公司赛诺菲（Sanofi）SASY.PA周四表示，将向其美国合作伙伴瑞杰纳隆（Regeneron）REGN.O支付10亿美元预付款，并根据里程碑达成情况再支付最高70亿美元，以此将四种新一代长效免疫学抗体纳入双方针对重磅湿疹药物Dupixent的合作框架。双方表示，此前围绕该合作项目引发的诉讼已达成和解，且将平分此次扩展合作所产生的成本和利润。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4S45N0BB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2023250504.SGD","LU1917777945.USD","LU0114720955.EUR","REGN","LU0320765992.SGD","LU2362541273.HKD","LU2468319806.SGD","BBH","LU2362540622.SGD","LU0109394709.USD","LU2106854487.HKD","LU2362541513.USD","LU2089984988.USD","LU0289739699.SGD","LU0823416689.USD","LU2324357040.USD","LU0882574055.USD","LU2237438978.USD","BK4585","LU0053666078.USD","IBB","BK4139","LU0889565916.HKD","TBXU","BK4588","LU0058720904.USD","LU0823434740.USD","IBBQ","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168736534","title":"赛诺菲与再生元制药达成合作协议，将均摊开发及商业化成本，共享未来利润","url":"https://stock-news.laohu8.com/highlight/detail?id=1168736534","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168736534?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 13:04","pubTimestamp":1790831085,"startTime":"0","endTime":"0","summary":"赛诺菲与再生元制药公司达成合作协议，双方将平均分摊开发与商业化成本，并共享未来所产生的利润。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0889565916.HKD","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","LU1974910355.USD","LU2089984988.USD","LU2106854487.HKD","LU2324357040.USD","TBXU","IBB","LU2362541513.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179424106","title":"赛诺菲与再生元将获10亿美元预付款 未来里程碑付款最高或达70亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179424106","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179424106?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 13:01","pubTimestamp":1790830872,"startTime":"0","endTime":"0","summary":"赛诺菲与再生元制药公司（Regeneron Pharmaceuticals）将获得10亿美元预付款，未来还有望获得最高70亿美元的里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0889565916.HKD","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","LU1974910355.USD","LU2089984988.USD","LU2106854487.HKD","LU2324357040.USD","TBXU","IBB","LU2362541513.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672801517","title":"临床试验显示，Regeneron的药物与诺和诺德的司美格鲁肽联用可将肌肉流失减少一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2672801517","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672801517?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 06:01","pubTimestamp":1790805704,"startTime":"0","endTime":"0","summary":"该公司表示，特雷沃格鲁马布单药治疗的安全性特征与司美格鲁肽相似，未出现意外副作用。Regeneron表示将不再推进该三联疗法。在试验的第一部分中，仅使用司美格鲁肽的患者在26周内瘦肌肉量减少了6.7%。与25毫克特雷沃格鲁马布联合使用时，肌肉量减少4.7%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4T45M1TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU2362540622.SGD","LU0823434583.USD","TBXU","LU1974910355.USD","LU2468319806.SGD","LU0320765992.SGD","LU1917777945.USD","LU0058720904.USD","LU2106854487.HKD","LU2237438978.USD","LU2362541273.HKD","IBBQ","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","LU0823416689.USD","BK4139","LU2023250504.SGD","BK4585","LU2362541513.USD","IBB","BBH","LU0882574055.USD","LU0053666078.USD","BK4588","REGN","LU2324357040.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671620101","title":"数据简报-大型制药公司纷纷转向中国寻求许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2671620101","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671620101?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 20:19","pubTimestamp":1790770785,"startTime":"0","endTime":"0","summary":"数据简报-大型制药公司纷纷转向中国寻求许可协议修改发稿日期，重写导语和标题，并在全文中将欧洲制药商加入名单路透9月30日-诺和诺德NOVOb.CO周二表示，将向江苏恒瑞医药600276.SS支付最高26亿美元，以获得一种试验性减肥药的权益，这使其成为最新一家获得中国研发药物授权的制药企业。中国生物技术公司通常保留国内权益 ，并将药品授权至海外，以换取预付款、里程碑付款以及专利使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4T45M0ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2433249047.HKD","SG9999001176.USD","LU0130517989.USD","LU2242644610.SGD","LU1989772840.SGD","BK0028","BK1588","LU2106854487.HKD","LU2361045086.USD","LU2461242641.AUD","HCM","IE0002141913.USD","LU2488822045.USD","LU0098860793.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2097828631.EUR","LU0477156953.USD","LU0648001328.SGD","LU0463099449.HKD","LU2324357040.USD","PAWZ","LU0289739699.SGD","LU1883839398.USD","GDOC","REGN","LU0868494708.USD","LU0289739343.SGD","LU1974910355.USD","SG9999015341.SGD","BK4581","LU0006306889.USD","LU0502904849.HKD","BK1587","LU0203345920.USD","IE00BN8TJ469.HKD","LU1699723380.USD","MRK","SG9999015358.SGD","LU0211331839.USD","LU0405327148.USD","LU1037948541.HKD","LU0868494617.USD","LU0053666078.USD","IE00BJJMRZ35.SGD","LU0511384066.AUD","BK4534","LU0238689110.USD","LU2362541273.HKD","IE00BBT3K403.USD","BK1191","LU1585245621.USD","PFE","LU1291159041.SGD","LU0889565916.HKD","IE00BLSP4452.SGD","BK4568","BMED","IE00BFTCPJ56.SGD","IXJ","LU1066051811.HKD","LU1989771016.USD","LU1781817850.SGD","LU2360032135.SGD","IE0002270589.USD","IE00B1BXHZ80.USD","LU0057025933.USD","LU1983299246.USD","LU0326950275.SGD","BK0239","LU0170899867.USD","LU0965509283.SGD","LU2237438978.USD","LU2362541513.USD","SG9999013999.USD","RXL","LU0124676726.USD","LU0234572021.USD","LU1969619763.USD","LU2125154778.USD","01276","IE00BJT1NW94.SGD","LU0607220059.USD","LU2491049909.HKD","LU1831875114.USD","SG9999001176.SGD","BBH","BK4533","LU1188198961.HKD","LU0265550359.USD","LU1941712348.USD","LU0472753341.HKD","LU1328615791.USD","LU2362540622.SGD","LU0225771236.USD","LU0985320562.USD","LU1997245094.SGD","LU2468319806.SGD","BK4599","LU0265550946.USD","LU0203347892.USD","BK0188","IE00BSNM7G36.USD","LU0405327494.USD","LU0306807586.USD","LU2580892862.HKD","XLV","LU2495084118.USD","LU1894683264.USD","LU0882574055.USD","BK1583","LU0965509010.AUD","IE00B3T34201.USD","LU1255011170.USD","LU0072461881.USD","LU1037948897.HKD","LU0109394709.USD","LU2328871848.SGD","LU1093756168.USD","BK4007","BK4139","BK1589","LU0070302665.USD","LU1116320901.HKD","LU1066051225.USD","LU1934455277.USD","LU1917777945.USD","LU0861579265.USD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","LU1923622614.USD","SG9999014542.SGD","LU2289578879.USD","LU2357627491.SGD","BK0196","LU0162691827.USD","LU0859254822.USD","FTXH","LU0455707207.USD","LU0114720955.EUR","LU0823416689.USD","LU1066051498.USD","LU1093756325.SGD","LU1146622755.USD","LU0321505439.SGD","LU0965509101.SGD","LU2097828557.USD","IE00BLSP4239.USD","IYH","LU0689626769.HKD","LU2491050154.USD","FHLC","LU2148510915.USD","PPH","LU0320765992.SGD","01801","BK4585","LU1941712264.USD","BK0060","LU2112291526.USD","SG9999011175.SGD","LU2097828805.USD","IE00B2B36J28.USD","LU0106261372.USD","SG9999003800.SGD","LU0069063385.USD","600276","LU0965508806.USD","BK4550","LU1655091616.SGD","LU2125154935.USD","00013","KURE","LU0244354667.USD","LU1116320737.USD","IE00B19Z3581.USD","LU1430594728.SGD","LU1580142542.USD","LU2580892789.USD","LU1894683348.USD","HK0000165453.HKD","LU2596442595.SGD","SG9999014575.USD","LU2097828474.EUR","BK4592","IBBQ","LU0266013472.USD","LU1069347547.HKD","03692","LU2491050071.SGD","SG9999001440.SGD","LU1032466523.USD","VHT","LU0985481810.HKD","SG9999002224.SGD","SG9999014559.SGD","IBB","LU2125909247.SGD","LU2361044949.HKD","LU0225284248.USD","LU0942090050.USD","BK4516","OZEM","SG9999014567.USD","TBXU","LU2125909593.SGD","JDOC","BK4559","TRUH","LU0058720904.USD","LU0149534421.HKD","LU1064131003.USD","LU1934455194.USD","IHE","LU1989772923.USD","LU0289961442.SGD","LU1162221912.USD","SG9999002232.USD","BK4588","LU0320765646.SGD","LU2023250843.SGD","LU0456855351.SGD","BK1161","IE0009355771.USD","SGXZ57979304.SGD","LU0306806265.USD","LU1023059063.AUD","LU2089984988.USD","LU1064130708.USD","LU0823434583.USD","LU1201861249.SGD","LU2097828714.EUR","LU1035773651.USD","LU0432979614.USD","LU1571399168.USD","LU0122379950.USD","LU0980610538.SGD","LU1997245177.USD","LU1820825898.SGD","LU1997244956.HKD","LU0320765489.SGD","LU2361044865.SGD","LU1929549753.HKD","LU0823434740.USD","LU1934455863.HKD","LU2023250504.SGD","LU0208291251.USD","HRTS","BK0183","LU0130102774.USD","LU1061106388.HKD","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671264188","title":"港股异动 | 中国生物制药(01177)涨近4% 附属与STADA就生物类似药达成战略合作 首付款获最高达5300万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671264188","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671264188?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 09:58","pubTimestamp":1790647094,"startTime":"0","endTime":"0","summary":"消息面上，中国生物制药发布公告，集团附属公司正大天晴药业集团股份有限公司与STADA Arzneimittel AG已就生物类似药达成战略合作，双方将携手提升生物类似药在全球多个地区的患者可及性。根据协议的条款及条件，正大天晴将获得首付款，并有权获得潜在开发、监管及销售里程碑付款，合计最高可达5300万欧元。STADA将持有该等生物类似药在授权区域内的上市许可，并享有独家销售及营销权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YS42.EUR","EUO","LU2322448957.HKD","MEURmain","LU2272731600.USD","XPH","LU1992135399.USD","BK1589","NBIE","BK1515","KCAI","01177","IE00B5TLWC47.USD","BK1191","LU1992135472.HKD","IBB","HK0000165453.HKD","LU2272731782.SGD","LU2473716301.USD","VXUS","LU2322448791.USD","BK4588","IE00BZ08YT58.USD","BK4585","BK1521","PPH","EURmain","FXE","LU2272731865.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}